Aptevo Therapeutics (APVO) Financials

$1.88

$0.14 (8.05%)

As on 08-Sep-2026 15:27EDT

Market cap

$3 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

0

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	-0.22	--	--	--	3.11	12.29
Cost of Revenue	0.12	0.24	0.35	17.11	17.88	18.99
Gross Profit	-0.12	-0.24	-0.35	-0.57	3.11	12.29
Operating Expenses	26.77	26.07	24.25	28.88	31.76	33.69
Operating Profit (EBIT)	-26.89	-26.31	-24.60	-28.88	-28.64	-21.40
Other Income	--	--	--	--	--	--
Profit before Tax	-26.41	-25.97	-24.13	-18.65	7.01	-29.41
Provision for Tax	--	--	--	-1.24	-35.66	-2.10
Profit after Tax (Net Income)	-26.41	-25.97	-24.13	-17.41	8.03	-27.31
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	8.03	-28.46

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	6.04	17.38	4.76	12.22	17.97	1.22
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	3.29	3.76	4.63	5.40	7.54	20.63
Current Liabilities	5.19	6.05	6.21	7.22	8.71	34.76
Total Liabilities	19.71	27.19	15.59	24.84	34.22	56.60

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	3.72	4.11	4.93	5.78	6.77	4.03
Current Assets	10.80	23.08	10.66	19.07	27.45	52.57
Total Assets	25.32	27.19	15.59	24.84	34.22	56.60
Total Debt*	4.21	4.63	4.63	5.40	9.54	16.72
Net Current Assets	--	17.03	4.45	11.84	18.74	17.81

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-25.59	-23.79	-11.73	-21.02	-21.68
Cash Flow from Investing Activities	--	--	--	--	-0.03	-0.71
Cash from Financing Activities	--	38.50	15.60	6.00	-2.62	26.16
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-51.01	-26.02	-5,885.37	--	--	--
Cash EPS ($)	--	-25.78	-5,799.51	--	--	--
Adjusted Book Value ($)	--	17.42	1,159.76	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-25.65	-5,801.22	--	--	--
Free Cash Flow per Share ($)	--	-25.65	-5,801.22	--	--	--

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-165.43	-178.73	-77.16	35.33	-88.19
ROE (%)	-225.50	-234.61	-284.28	-115.32	83.66	-306.72
ROA (%)	-115.24	-121.38	-119.36	-58.96	17.68	-49.59
EBIT Margin (%)	9,114.55	--	--	--	225.24	-174.10
Net Margin (%)	12,003.64	--	--	--	257.77	-222.20
Cash Profit Margin (%)	0.07	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	-0.75	1.85
EBIT Growth (%)	16.54	-7.61	-29.38	-365.90	132.78	22.16
Net Profit Growth (%)	-9.92	-7.61	-38.59	-316.91	129.39	-53.88
EPS Growth (%)	99.47	1.00	--	--	--	--
Book Value Growth (%)	-96.83	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	0.00	-0.36	0.00	--	--	--
Price / Book Value	0.70	0.54	0.00	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.39	0.29	0.17	0.64	-1.66	1.40
Close Price ($)	4.44	9.43	1,551.60	106,080.48	1,359,705.60	4,612,449.60
High Price ($)	59.40	1,976.40	143,856.00	1,512,086.40	5,010,690.96	25,324,516.80
Low Price ($)	3.84	9.07	1,314.00	89,084.16	1,136,995.20	3,739,190.40
Market Cap ($ Cr)	3.15	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.27	0.97	0.44	0.53	13.75
Short term debt to equity ratio	0.15	0.05	--	--	0.11	9.59
Current Ratio	2.08	3.82	1.72	2.64	3.15	1.51
Quick Ratio	2.08	--	--	--	2.97	1.42
Interest Coverage	--	--	--	--	0.20	-3.03

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	80.28	29.81
Asset Turnover	-0.01	--	--	--	0.07	0.22
Receivable days	--	--	--	--	361.50	89.63
Inventory Days	--	--	--	33.54	47.52	75.62
Payable days	--	2,990.48	3,650.94	79.88	71.09	86.97
Cash Conversion Cycle	--	--	--	--	337.93	78.29

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.